For educational and research reference only. The peptides in this class are laboratory research compounds not approved for human use unless a profile says otherwise.
Overview
The BPC family and tissue repair peptide class encompasses endogenous and synthetic peptide sequences that promote healing of musculoskeletal structures, skin, mucosa, and neural tissue through mechanisms including angiogenesis stimulation, collagen synthesis, anti-inflammatory signaling, and stem cell mobilization. Key members include BPC-157 (derived from gastric juice), TB-500 (Thymosin Beta-4 fragment), and GHK-Cu (a tripeptide copper complex). These compounds are broadly studied in animal models for tendon, ligament, muscle, and gut repair.
Mechanism of Action
Tissue repair peptides operate through diverse but complementary mechanisms: BPC-157 upregulates growth hormone receptors in fibroblasts and activates the FAK-paxillin pathway for cell migration; TB-500 binds G-actin and regulates actin dynamics critical for cell motility and angiogenesis; GHK-Cu modulates copper-dependent lysyl oxidase for collagen crosslinking; LL-37 provides antimicrobial coverage while signaling keratinocyte migration; KPV exerts anti-inflammatory effects through melanocortin receptors. These mechanisms support coordinated tissue remodeling.
Clinical Landscape
None of the primary tissue repair research peptides have received FDA approval for musculoskeletal indications. BPC-157 and TB-500 remain investigational compounds with no completed human clinical trials as of 2026. GHK-Cu is widely used in topical cosmeceutical formulations. LL-37 has been studied in wound care and dermatology clinical trials. KPV has been evaluated in inflammatory bowel disease models. All are available only for research purposes.
Research Considerations
Animal model findings in tissue repair research require careful consideration when interpreting translational relevance. Key variables include route of administration (systemic vs. local/intra-articular), dosing frequency relative to tissue turnover rates, the specific tissue type being studied (tendon vs. muscle vs. gut vs. skin), and the presence or absence of injury induction in the model. Combination protocols using BPC-157 + TB-500 are commonly studied based on their complementary actin and angiogenesis mechanisms.
Peptides in this class
- BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It has been extensively studied for its potential regenerative and protective properties in various tissue types.
- TB-500
TB-500 is the N-terminally acetylated 17-23 fragment of thymosin beta-4 (Ac-LKKTETQ, CAS 885340-08-9), identified analytically in TB-500 product by HPLC/high-resolution MS (PMID 22962027). It is studied for tissue repair, cell migration, and blood vessel formation. Product content is not reliable: a 2023 analysis of TB500/TB1000 sold online found contents inconsistent with the label, including full-length 43-residue thymosin beta-4 in place of the heptapeptide (PMID 36482504).
- GHK-Cu
GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. It has been extensively studied for wound healing, skin rejuvenation, and tissue remodeling.
- LL-37
LL-37 is a human cathelicidin antimicrobial peptide that plays a crucial role in innate immunity. It has broad-spectrum antimicrobial activity and immunomodulatory properties.
- KPV
KPV is a naturally-occurring tripeptide derived from the C-terminus of alpha-melanocyte stimulating hormone (α-MSH), demonstrating potent anti-inflammatory effects independent of melanocortin receptor activation.